NCT06079502

Brief Summary

The aim of this study is to compare effect of intradialytic NMES versus resistive training on physical measures and fatigue in HDP.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

October 20, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

October 6, 2023

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Assessing the change in maximal strength of quadriceps and calf muscles

    By using a Hand held dynamometer: A Kern-type standardized traction dynamometer (Kern CH50 50KG dynamometer) will used to assess the maximal strength of quadriceps and calf muscles will estimate. The patient will remain seated in a fixed chair so the back will supported on the back rest with the hip and knee at 90°, the subject will be asked to exert the greatest possible force without holding the chair with his/her arms,the values of muscular strength variables will be the mean of 3 consecutive measurements obtained by the same investigator to minimize errors

    at baseline and after 16 weeks of intervention

  • Assessing the change in predicted peak vo2 max

    By using a 6-minute walk test (6MWT): It consisted of measuring the maximum distance covered during a 6 min period at an active pace, along a 20 m corridor near the HD unit. At the end of the test period, the total distance travelled was recorded by means of a standardized odometer,that will be used to calculate predicted peak vo2 by using the following equation Mean Peak VO2( ml /kg/min)= 4. 948+ 0. 023\*Mean 6 MWD (meters) (SEE 1.1 ml/ kg/ min), standard error of estimate (SEE).

    at baseline and after 16 weeks of intervention

Secondary Outcomes (2)

  • Assessing the change in physical and psychological fatigue

    at baseline and after 16 weeks of intervention

  • Assessing the change in Dialysis efficiency

    at baseline and after 16 weeks of intervention

Study Arms (2)

Neuromuscular Electrical Stimulation group

EXPERIMENTAL

Thirty patients will receive a supervised program of intradialytic NMES two times per week for 16weeks with medical treatment.

Device: Neuromuscular Electrical Stimulation

resistive training group

EXPERIMENTAL

Thirty patients will receive a supervised program of intradialytic resistive training two times per week for 16weeks with medical treatment.

Other: resistive training program

Interventions

A supervised program of intradialytic NMES of the quadriceps and calf muscles of both lower limbs with different phases, types and current intensity. The electrical stimulation program will included (total time, intensity, contraction-relaxation phase time): a toning program in the first two weeks.

Neuromuscular Electrical Stimulation group

Part one: Warming up for 5 minutes in the form of lower limbs range of motion (active free) exercise from supine position. Part two: The main part is the resistive training for quadriceps and calf muscles from supine position using weights in the form of sand bags for 20 min. Part three: Cooling down for 5 minutes in the form of lower limbs range of motion (active free) exercise from supine position. The training parameters: The exercise training will be done during the first 2 hours of HD session using free leg weights. The patient will assume a supine lying position on the treatment plinth and perform the exercises for every lower limb separately while the other limb will be supported on the plinth by therapist or the patient himself. Resistance will be placed at the malleoli level in the distal third of the leg.

resistive training group

Eligibility Criteria

Age40 Years - 55 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients of both sexes, with CKF on HD for more than 3 years.
  • Age between 40 to 55 years old.
  • BMI is between 25 and 29.9 kg/m2.

You may not qualify if:

  • Patients who have one of the following contraindications to the interventions or affect the results
  • Cognitive impairment that prevented them from performing the evaluations and who were unable to understand and sign the written informed consent.
  • Stroke
  • Smokers
  • Anemic patients
  • Osteoarticular or disabling musculoskeletal disorders
  • Uncontrolled hypertension (systolic blood pressure\>230 mm Hg and diastolic blood pressure\>120 mm Hg)
  • Patients with coronary artery disease or heart failure.
  • Diabetic patients
  • Infectious diseases and chest diseases
  • Active smokers' patients with peripheral vascular disease in the lower limbs such as deep vein thrombosis or thromboangiitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient clinic faculty of physical therapy cairo university

Dokki, Egypt

RECRUITING

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Asmaa Yacoub

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 6, 2023

First Posted

October 12, 2023

Study Start

October 20, 2023

Primary Completion

May 30, 2024

Study Completion

July 30, 2024

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations